Pegasys 135 mcg/0,5 ml soluţie injectabilă în seringă preumplută Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pegasys 135 mcg/0,5 ml soluţie injectabilă în seringă preumplută

f.hoffmann-la roche, ltd. - peginterferon alfa-2a - soluţie injectabilă în seringă preumplută - 135 mcg/0,5 ml

Pegasys 180 mcg/0,5 ml soluţie injectabilă în seringă preumplută Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pegasys 180 mcg/0,5 ml soluţie injectabilă în seringă preumplută

f.hoffmann-la roche, ltd. - peginterferon alfa-2a - soluţie injectabilă în seringă preumplută - 180 mcg/0,5 ml

Daclavir 60 mg comprimate filmate Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

daclavir 60 mg comprimate filmate

llc pube global - daclatasvirum - comprimate filmate - 60 mg

Virodacla 60 mg comprimate filmate Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

virodacla 60 mg comprimate filmate

incepta pharmaceuticals ltd. - daclatasvirum - comprimate filmate - 60 mg

Pegnano 180 mcg/0,5 ml soluţie injectabilă în seringă preumplută Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pegnano 180 mcg/0,5 ml soluţie injectabilă în seringă preumplută

nanogen pharmaceutical biotechnology company ltd. - peginterferon alfa-2a - soluţie injectabilă în seringă preumplută - 180 mcg/0,5 ml

Jayempi Euroopa Liit - rumeenia - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - respingerea grefei - imunosupresoare - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Velsof 400 mg/100 mg comprimate filmate Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

velsof 400 mg/100 mg comprimate filmate

hetero labs limited, m/s. hetero corporate - sofosbuvir + velpatasvir - comprimate filmate - 400 mg/100 mg

Mercaptopurin-BP 50 mg comprimate Moldova - rumeenia - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mercaptopurin-bp 50 mg comprimate

sc balkan pharmaceuticals srl - mercaptopurinum - comprimate - 50 mg

PURI - NETHOL 50 mg Rumeenia - rumeenia - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

puri - nethol 50 mg

excella gmbh & co. kg - germania - mercaptopurinum - compr. - 50mg - antimetaboliti analogi ai bazelor purinice

Maviret Euroopa Liit - rumeenia - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatita c, cronică - antivirale pentru uz sistemic - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.